GFP
EVGN icon

Gryphon Financial Partners’s Evogene EVGN Stock Holding History

Gryphon Financial Partners’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3
Closed – – 377
2018
Q2 		$0 Hold
3
– – ﹤0.01% 976
2018
Q1 		$0 Sell
3
-22
-88% -$819 ﹤0.01% 981
2017
Q4 		$1K Buy
+25
New +$982 ﹤0.01% 954

Other funds holding EVGN

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Moon Capital Management New York $166M AUM 54.85% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Gryphon Financial Partners's EVGN Position: Q3 2018 in Review

Gryphon Financial Partners sold out of Evogene (EVGN) in Q3 2018, closing a stake of 3 shares.

Gryphon Financial Partners first reported a position in EVGN in Q4 2017 and held it in 3 quarters. The position peaked at $1K in Q4 2017. 23 funds tracked by Wall St. Rank hold EVGN as of Q3 2018.

  • Gryphon Financial Partners reported no remaining Evogene position as of Q3 2018 after selling out during the quarter.
  • Gryphon Financial Partners sold 3 Evogene shares in Q3 2018.
  • Gryphon Financial Partners first reported a position in Evogene in Q4 2017 and held it in 3 quarters.
  • Gryphon Financial Partners's Evogene position peaked at $1K in Q4 2017.
  • 23 funds tracked by Wall St. Rank held Evogene as of Q3 2018.

Based on Gryphon Financial Partners's 13F filing for Q3 2018, filed 6 Nov 2018.